FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200577314> ?p ?o ?g. }

• W4200577314 endingPage "931" @default.
• W4200577314 startingPage "926" @default.
• W4200577314 abstract "The present study assesses the implementation and the impact after 2 years of a school-based human papillomavirus (HPV) vaccination program in a Brazilian city. A prospective study assessing the implementation of the program, offering quadrivalent HPV vaccine in two annual doses to girls and boys aged from 9 to 10 years old. The program was started in the city of Indaiatuba, state of São Paulo, Brazil, in 2018, and had authorization from the National Immunization Program. The number of HPV vaccine first doses applied and the coverage in 2018 was calculated and compared to the year 2017. There were described events that have influenced the results. The program invited 4,878 children through schools (87.1% of the target population), and 7.5% refused vaccination. Several concurrent events required or competed for health professionals of the vaccination teams. The coverage of the first dose (between 9 and 10 years old) was 16.1% in 2017 and increased to 50.5% in 2018 (p < 0.0001). The first dose in all ages increased 78% in 2018 compared with 2017 (6,636/3,733). Competing demands over the program continued in 2019, and the first dose coverage dropped (26.9%). For 2020, a municipal law instituted school-based vaccination and the creation of dedicated teams for vaccination, and these strategies are waiting to be tested. School-based annual HPV vaccination in children between 9 and 10 years old was feasible and increased vaccination coverage, regardless of gender, although the program was vulnerable to competing events. O presente estudo avalia a implantação de um programa de vacinação contra o papilomavírus humano (HPV) em escolas de uma cidade brasileira e o impacto após 2 anos. MéTODOS: Estudo prospectivo para avaliar a implementação do programa, oferecendo a vacina quadrivalente contra o HPV em duas doses anuais, para meninas e meninos de 9 a 10 anos. O programa foi autorizado pelo Programa Nacional de Imunizações na cidade de Indaiatuba, estado de São Paulo, Brasil, e teve início em 2018. A cobertura anual da primeira dose foi comparada ao ano de 2017, e os eventos que influenciaram os resultados foram descritos. O programa convidou 4.878 crianças por meio das escolas (87,1% da população-alvo) e 7,5% recusou a vacinação. Vários eventos concorrentes exigiram ou competiram pelos profissionais de saúde das equipes de vacinação. A cobertura da primeira dose (9 a 10 anos) foi de 16,1% em 2017 e aumentou para 50,5% em 2018 (p < 0,0001). A primeira dose em todas as idades aumentou 78% em 2018 em comparação com 2017 (6.636/3.733). As demandas concorrentes sobre o programa continuaram em 2019, e a cobertura da primeira dose caiu (26,9%). Para 2020, uma lei municipal instituiu a vacinação nas escolas e a criação de equipes dedicadas à vacinação, e estas estratégias aguardam para ser testadas. CONCLUSãO: A vacinação anual contra o HPV em base escolar nas idades de 9 a 10 anos foi viável e aumentou a cobertura vacinal, independentemente do gênero, embora o programa fosse vulnerável a eventos concorrentes." @default.
• W4200577314 created "2021-12-31" @default.
• W4200577314 creator A5006342738 @default.
• W4200577314 creator A5008097105 @default.
• W4200577314 creator A5008907993 @default.
• W4200577314 creator A5011570780 @default.
• W4200577314 creator A5040037921 @default.
• W4200577314 creator A5071753660 @default.
• W4200577314 creator A5083214998 @default.
• W4200577314 creator A5084933228 @default.
• W4200577314 date "2021-12-01" @default.
• W4200577314 modified "2023-10-03" @default.
• W4200577314 title "School-based HPV Vaccination: The Challenges in a Brazilian Initiative" @default.
• W4200577314 cites W2014164721 @default.
• W4200577314 cites W2036530279 @default.
• W4200577314 cites W2139605865 @default.
• W4200577314 cites W2565658422 @default.
• W4200577314 cites W2806781062 @default.
• W4200577314 cites W2894633078 @default.
• W4200577314 cites W2896597103 @default.
• W4200577314 cites W2906350926 @default.
• W4200577314 cites W2967044977 @default.
• W4200577314 cites W3003249044 @default.
• W4200577314 cites W3090300247 @default.
• W4200577314 cites W4299311087 @default.
• W4200577314 doi "https://doi.org/10.1055/s-0041-1740279" @default.
• W4200577314 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34933386" @default.
• W4200577314 hasPublicationYear "2021" @default.
• W4200577314 type Work @default.
• W4200577314 citedByCount "6" @default.
• W4200577314 countsByYear W42005773142021 @default.
• W4200577314 countsByYear W42005773142022 @default.
• W4200577314 countsByYear W42005773142023 @default.
• W4200577314 crossrefType "journal-article" @default.
• W4200577314 hasAuthorship W4200577314A5006342738 @default.
• W4200577314 hasAuthorship W4200577314A5008097105 @default.
• W4200577314 hasAuthorship W4200577314A5008907993 @default.
• W4200577314 hasAuthorship W4200577314A5011570780 @default.
• W4200577314 hasAuthorship W4200577314A5040037921 @default.
• W4200577314 hasAuthorship W4200577314A5071753660 @default.
• W4200577314 hasAuthorship W4200577314A5083214998 @default.
• W4200577314 hasAuthorship W4200577314A5084933228 @default.
• W4200577314 hasBestOaLocation W42005773141 @default.
• W4200577314 hasConcept C121608353 @default.
• W4200577314 hasConcept C126322002 @default.
• W4200577314 hasConcept C144024400 @default.
• W4200577314 hasConcept C147483822 @default.
• W4200577314 hasConcept C149923435 @default.
• W4200577314 hasConcept C187212893 @default.
• W4200577314 hasConcept C203014093 @default.
• W4200577314 hasConcept C22070199 @default.
• W4200577314 hasConcept C2778220009 @default.
• W4200577314 hasConcept C2780801004 @default.
• W4200577314 hasConcept C2908647359 @default.
• W4200577314 hasConcept C2909654208 @default.
• W4200577314 hasConcept C2994532551 @default.
• W4200577314 hasConcept C512399662 @default.
• W4200577314 hasConcept C71924100 @default.
• W4200577314 hasConcept C99454951 @default.
• W4200577314 hasConceptScore W4200577314C121608353 @default.
• W4200577314 hasConceptScore W4200577314C126322002 @default.
• W4200577314 hasConceptScore W4200577314C144024400 @default.
• W4200577314 hasConceptScore W4200577314C147483822 @default.
• W4200577314 hasConceptScore W4200577314C149923435 @default.
• W4200577314 hasConceptScore W4200577314C187212893 @default.
• W4200577314 hasConceptScore W4200577314C203014093 @default.
• W4200577314 hasConceptScore W4200577314C22070199 @default.
• W4200577314 hasConceptScore W4200577314C2778220009 @default.
• W4200577314 hasConceptScore W4200577314C2780801004 @default.
• W4200577314 hasConceptScore W4200577314C2908647359 @default.
• W4200577314 hasConceptScore W4200577314C2909654208 @default.
• W4200577314 hasConceptScore W4200577314C2994532551 @default.
• W4200577314 hasConceptScore W4200577314C512399662 @default.
• W4200577314 hasConceptScore W4200577314C71924100 @default.
• W4200577314 hasConceptScore W4200577314C99454951 @default.
• W4200577314 hasIssue "12" @default.
• W4200577314 hasLocation W42005773141 @default.
• W4200577314 hasLocation W42005773142 @default.
• W4200577314 hasLocation W42005773143 @default.
• W4200577314 hasOpenAccess W4200577314 @default.
• W4200577314 hasPrimaryLocation W42005773141 @default.
• W4200577314 hasRelatedWork W1975501975 @default.
• W4200577314 hasRelatedWork W2041694303 @default.
• W4200577314 hasRelatedWork W2137857817 @default.
• W4200577314 hasRelatedWork W2413850697 @default.
• W4200577314 hasRelatedWork W2425838225 @default.
• W4200577314 hasRelatedWork W2565658422 @default.
• W4200577314 hasRelatedWork W3081643511 @default.
• W4200577314 hasRelatedWork W4247913852 @default.
• W4200577314 hasRelatedWork W4303685087 @default.
• W4200577314 hasRelatedWork W4312892286 @default.
• W4200577314 hasVolume "43" @default.
• W4200577314 isParatext "false" @default.
• W4200577314 isRetracted "false" @default.
• W4200577314 workType "article" @default.